Pharmacoepidemiology: An Overview.
adverse drug reaction
drug safety
effectiveness
patient safety
pharmacoepidemiology
pharmacovigilance
regulatory decision
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
10 Nov 2023
10 Nov 2023
Historique:
received:
28
09
2023
revised:
04
11
2023
accepted:
08
11
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
The aims of this review are to provide a comprehensive overview of the definition and scope of pharmacoepidemiology, to summarize the study designs and methodologies used in the field, to discuss the future trends in the field and new methodologies to address bias and confounding, and finally to give some recommendations to clinicians interested in pharmacoepidemiologic research. Because drug efficacy and safety from randomized clinical trials do not reflect the real-world situation, pharmacoepidemiological studies on drug safety monitoring and drug effectiveness in large numbers of people are needed by healthcare professionals and regulatory institutions. We aim to highlight the importance of pharmacoepidemiologic research in informing evidence-based medicine and public health policy. The development of new designs and methodologies for the generation of valid evidence, as well as new initiatives to provide guidance and recommendations on how to incorporate real-world evidence into the drug development process, are reported on. In addition, we have touched on the implication of artificial intelligence in the management of real-world data. This overview aims to summarize all important aspects to consider when conducting or interpreting a pharmacoepidemiologic study.
Identifiants
pubmed: 38002647
pii: jcm12227033
doi: 10.3390/jcm12227033
pmc: PMC10672708
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
N Engl J Med. 2016 Jun 2;374(22):2175-81
pubmed: 27248626
Expert Opin Drug Saf. 2018 Dec;17(12):1155-1159
pubmed: 30412009
J Eval Clin Pract. 2018 Jun;24(3):502-507
pubmed: 29658192
Stat Methods Med Res. 2009 Feb;18(1):53-65
pubmed: 18765504
Clin Pharmacol Ther. 2023 Jan;113(1):135-151
pubmed: 36254408
Med Care. 2013 Sep;51(9):789-96
pubmed: 23685406
Br J Clin Pharmacol. 2012 Jun;73(6):973-8
pubmed: 22360737
Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):245-252
pubmed: 29327451
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Pharm World Sci. 1995 May 26;17(3):61-6
pubmed: 7550051
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):9-18
pubmed: 36216785
Therapie. 2019 Apr;74(2):169-174
pubmed: 30389102
Drugs Real World Outcomes. 2022 Dec;9(4):543-550
pubmed: 36107390
J Clin Med. 2022 Jun 20;11(12):
pubmed: 35743619
BMC Med Res Methodol. 2022 Nov 5;22(1):287
pubmed: 36335315
J Am Med Inform Assoc. 2003 Mar-Apr;10(2):115-28
pubmed: 12595401
BMC Med. 2016 Feb 04;14:10
pubmed: 26843061
Res Social Adm Pharm. 2022 Feb;18(2):2283-2300
pubmed: 34246572
Epidemiology. 2010 May;21(3):383-8
pubmed: 20335814
Value Health. 2022 Oct;25(10):1663-1672
pubmed: 36241338
Med Ref Serv Q. 2021 Apr-Jun;40(2):215-223
pubmed: 33970822
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
J Med Econ. 2019 Jun;22(6):545-553
pubmed: 30816067
Drug Saf. 2022 Jul;45(7):747-754
pubmed: 35729468
JAMA. 2022 Dec 27;328(24):2446-2447
pubmed: 36508210
J Clin Pharmacol. 2006 Jan;46(1):6-9
pubmed: 16397278
Can J Cardiol. 2016 Feb;32(2):259-65
pubmed: 26315351
Br Med J (Clin Res Ed). 1984 Oct 13;289(6450):940-1
pubmed: 6435731
Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):817-826
pubmed: 35621007
Pharmacotherapy. 2010 Oct;30(10):973-84
pubmed: 20874034
Am J Med. 2009 Feb;122(2):114-20
pubmed: 19185083
Front Pharmacol. 2021 Sep 07;12:723427
pubmed: 34557096
Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):537-54
pubmed: 20354968
Drug Saf. 2023 Aug;46(8):711-713
pubmed: 37306853
Clin Pharmacol Ther. 2020 Aug;108(2):228-235
pubmed: 32243569
Drug Saf. 2011 Oct 1;34(10):861-8
pubmed: 21879780
Br J Clin Pharmacol. 2022 Mar;88(3):1235-1245
pubmed: 34468999
Front Big Data. 2021 Jul 12;4:727856
pubmed: 34322667
J Clin Epidemiol. 2016 Oct;78:101-107
pubmed: 26976053
Pharmacoepidemiol Drug Saf. 2022 Nov;31(11):1140-1152
pubmed: 35984046
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1201-1212
pubmed: 31823482
Annu Rev Public Health. 1995;16:61-81
pubmed: 7639884
Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1378-1386
pubmed: 28752670
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717
Curr Epidemiol Rep. 2017;4(4):281-287
pubmed: 29226066
Pharmacoepidemiol Drug Saf. 2005 Aug;14(8):589-95
pubmed: 15918159
Evid Based Ment Health. 2020 May;23(2):83-87
pubmed: 32139442
Ther Adv Drug Saf. 2019 May 31;10:2042098619854010
pubmed: 31210923
Therapie. 2016 Apr;71(2):211-6
pubmed: 27080840
Value Health. 2017 Jul - Aug;20(7):858-865
pubmed: 28712614
Med Clin (Barc). 2020 Mar 13;154(5):178-184
pubmed: 31771857